Metropolis Healthcare is currently trading at Rs. 2208.85, up by 21.85 points or 1.00% from its previous closing of Rs. 2187.00 on the BSE.
The scrip opened at Rs. 2230.75 and has touched a high and low of Rs. 2250.00 and Rs. 2205.00 respectively. So far 8334 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 2306.85 on 10-Oct-2024 and a 52 week low of Rs. 1450.05 on 12-Jan-2024.
Last one week high and low of the scrip stood at Rs. 2250.00 and Rs. 2065.80 respectively. The current market cap of the company is Rs. 11414.93 crore.
The promoters holding in the company stood at 49.43%, while Institutions and Non-Institutions held 46.58% and 3.99% respectively.
Metropolis Healthcare has received approval for acquisition of the 100% stake in Core Diagnostics, India, from its existing shareholder, Core Diagnostics (Mauritius) for a total purchase consideration of Rs 246.83 crore to be discharged partly by cash and partly by way of preferential issue and allotment of equity shares of the Company (by way of share swap) subject to approval of the shareholders of the Company. Pursuant to the completion of acquisition, Core Diagnostics will become a wholly owned subsidiary of the Company. The Board of Directors of the Company at its meeting held on December 09, 2024 has inter-alia, approved the same.
Metropolis Healthcare is engaged in the business of providing pathology and related healthcare services.
Company Name | CMP |
---|---|
Apollo Hospital Ent. | 7236.35 |
Max Healthcare Inst | 1193.20 |
Narayana Hrudayalay | 1280.95 |
Aster DM Healthcare | 494.95 |
Global Health | 1133.80 |
View more.. |